We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$13.5B
AUM Growth
+$829M
(+6.5%)
Cap. Flow
-$2.52B
Cap. Flow
% of AUM
-18.66%
Top 10 Holdings %
Top 10 Hldgs %
16.93%
Holding
671
New
60
Increased
214
Reduced
141
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$58.5M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$31.2M |
| 3 |
Apple
AAPL
|
+$24.7M |
| 4 |
NCR Voyix
VYX
|
+$23.5M |
| 5 |
Amgen
AMGN
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$55.5M |
| 2 |
AMT.PRA
American Tower Corporation
AMT.PRA
|
+$53.6M |
| 3 |
Meta Platforms (Facebook)
META
|
+$48.2M |
| 4 |
EXCU
Exelon Corporation
EXCU
|
+$46.4M |
| 5 |
Costco
COST
|
+$37.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11% |
| 2 | Technology | 9.33% |
| 3 | Healthcare | 8.36% |
| 4 | Industrials | 6.68% |
| 5 | Communication Services | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Baxter International
BAX
$11.2B
| $83.1M | 0.61% |
1,373,191
-154,416
| -10% | -$8.77M |
|
27
GE Aerospace
GE
$362B
| $82.7M | 0.61% |
638,649
+1,665
| +0.3% | +$228K |
|
28
Merck
MRK
$322B
| $80.7M | 0.6% |
1,319,642
+1,441
| +0.1% | +$87.7K |
|
29
Chevron
CVX
$387B
| $78M | 0.58% |
748,075
+48,884
| +7% | +$5.18M |
|
30
CALL
Goldman Sachs
GS
$317B
| $75.4M | 0.56% |
+340,000
| New | +$75.5M |
|
31
PepsiCo
PEP
$184B
| $72.2M | 0.53% |
625,265
+7,900
| +1% | +$906K |
|
32
Starbucks
SBUX
$118B
| $71.6M | 0.53% |
1,228,558
-232,584
| -16% | -$14.1M |
|
33
Coca-Cola
KO
$349B
| $70.7M | 0.52% |
1,575,677
+16,627
| +1% | +$735K |
|
34
AT&T
T
$160B
| $69.3M | 0.51% |
2,431,562
-3,461
| -0.1% | -$102K |
|
35
Pfizer
PFE
$143B
| $67.2M | 0.5% |
2,110,108
-153,501
| -7% | -$4.84M |
|
36
Philip Morris
PM
$298B
| $66M | 0.49% |
562,081
+24,817
| +5% | +$2.87M |
|
37
Delta Air Lines
DAL
$53.9B
| $65.9M | 0.49% |
1,226,623
+44,968
| +4% | +$2.2M |
|
38
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $65.7M | 0.49% |
50,091
-1,413
| -3% | -$1.8M |
|
39
Intercontinental Exchange
ICE
$81B
| $63.3M | 0.47% |
959,680
+39,801
| +4% | +$2.44M |
|
|
BDXA
40
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $59.5M | 0.44% |
+1,086,994
| New | +$58.5M |
|
|
AET
41
DELISTED
Aetna Inc
AET
| $57.5M | 0.42% |
378,423
-1,426
| -0.4% | -$202K |
|
|
TMUSP
42
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $57.2M | 0.42% |
580,203
-36,435
| -6% | -$3.87M |
|
43
SLB Ltd
SLB
$70.6B
| $56.9M | 0.42% |
863,916
-22,820
| -3% | -$1.64M |
|
44
Honeywell
HON
$78B
| $55.2M | 0.41% |
458,250
+5,974
| +1% | +$705K |
|
45
RTX Corp
RTX
$282B
| $53M | 0.39% |
689,860
+2,864
| +0.4% | +$215K |
|
46
Bank of America Series L
BAC.PRL
$3.93B
| $51M | 0.38% |
40,416
-1,019
| -2% | -$1.26M |
|
47
Booking.com
BKNG
$134B
| $49.4M | 0.37% |
660,250
-114,175
| -15% | -$8.37M |
|
|
48
PUT
Meta Platforms (Facebook)
META
$1.54T
| $49.3M | 0.36% |
+326,700
| New | +$48.6M |
|
|
AMT.PRB
49
DELISTED
American Tower Corporation
AMT.PRB
| $49.3M | 0.36% |
406,834
+141,819
| +54% | +$16.7M |
|
50
Lowe's Companies
LOW
$113B
| $48M | 0.35% |
619,298
-5,001
| -0.8% | -$409K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Calamos Advisors held 671 positions worth $13.5B, up 6.5% from $12.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Calamos Advisors withdrew a net $2.52B in Q2 2017, closing 65 positions and reducing 141 holdings. Its most notable exit was American Tower Corporation, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 worth $59.5M.
- Calamos Advisors's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 1,086,994 shares worth $59.5M.
- Calamos Advisors added most to Alexion Pharmaceuticals in Q2 2017, an estimated $31.2M increase.
- Calamos Advisors's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $55.5M.
- Calamos Advisors fully exited American Tower Corporation in Q2 2017, selling an estimated $53.6M.
- Calamos Advisors's ten largest holdings make up 17% of its $13.5B portfolio in Q2 2017.
- Calamos Advisors opened 60 new positions and closed 65 in Q2 2017.
- Calamos Advisors's portfolio value rose 6.5% quarter-over-quarter to $13.5B.
Based on Calamos Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.